{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:54Z","timestamp":1792047834435,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1D1A1B01014116"],"award-info":[{"award-number":["2016R1D1A1B01014116"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C2923"],"award-info":[{"award-number":["HI15C2923"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI18C1337"],"award-info":[{"award-number":["HI18C1337"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cyto.2019.02.010","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T06:50:39Z","timestamp":1552114239000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Inhaled delivery of Interferon-lambda restricts epithelial-derived Th2 inflammation in allergic asthma"],"prefix":"10.1016","volume":"119","author":[{"given":"Jina","family":"Won","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Hee","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.02.010_b0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/imr.12557","article-title":"Innate and adaptive type 2 immunity in lung allergic inflammation","volume":"278","author":"Kubo","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2019.02.010_b0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaip.2017.05.001","article-title":"Asthma exacerbations: pathogenesis, prevention, and treatment","volume":"5","author":"Castillo","year":"2017","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"10.1016\/j.cyto.2019.02.010_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.07.013","article-title":"Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma","volume":"134","author":"Patel","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2019.02.010_b0020","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fimmu.2018.00986","article-title":"Initial influenza virus replication can be limited in allergic asthma through rapid induction of type III interferons in respiratory epithelium","volume":"9","author":"An","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2019.02.010_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ni.3308","article-title":"Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells","volume":"17","author":"Duerr","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2019.02.010_b0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2016-0174OC","article-title":"The Superiority of IFN-\u03bb as a therapeutic candidate to control acute influenza viral lung infection","volume":"56","author":"Kim","year":"2017","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.cyto.2019.02.010_b0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2019.02.010_b0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.cyto.2019.02.010_b0045","first-page":"349575","article-title":"Interferon lambda: a new sword in cancer immunotherapy","author":"Lasfar","year":"2011","journal-title":"Clin. Dev. Immunol. 2011"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:52:27Z","timestamp":1760907147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619300560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":9,"alternative-id":["S1043466619300560"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.02.010","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled delivery of Interferon-lambda restricts epithelial-derived Th2 inflammation in allergic asthma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}